$58.40
Today
as of Jul 22, 16:46 ET
Last 30 days
Recent Press Releases & News
BMRN: What does Argus have to say about BMRN?
2 Reasons to Avoid BMRN and 1 Stock to Buy Instead
BMRN: Lowering target price to $65.00
Overview
52-week range
$49
$66
54% of range
Avg surprise (last 3)
+21.6%
Avg reaction (last 2)
+0.5%
50% positive
Latest IV / EM
51%
EM ±11.6% · $58 · Aug 21
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Mon May 4, 2026 | Mar/2026 | $0.58 | $0.78 | -25.6% | -40.8% | +2.6% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.16 | — | — | — | — | financials |
| Mon Aug 4, 2025 | Jun/2025 | $1.25 | $0.80 | +56.2% | — | — | earnings |
| Thu May 1, 2025 | Mar/2025 | $0.98 | $0.73 | +34.2% | — | -1.5% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $0.55 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $0.55 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $0.46 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $0.21 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $0.29 | — | — | — | — | financials |
Upcoming
| Date | Fiscal | Time | EPS Est | LY EPS | YoY %Δ |
|---|---|---|---|---|---|
| Mon Aug 3, 2026 | Jun/2026 | OTHER | $0.79 | $1.25 | -36.8% |
Financials
Income statement (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — |
| Cost of revenue | $195M | — | $140M | $150M | $152M | — | $188M | $130M |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $130M | — | $-47M | $277M | $224M | — | $114M | $120M |
| Net income | $106M | — | $-31M | $241M | $186M | — | $106M | $107M |
| EPS (diluted) | $0.54 | — | $-0.16 | $1.23 | $0.95 | — | $0.55 | $0.55 |
Balance sheet (quarterly)
| Metric | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 | Jun 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $2.22B | $1.31B | $1.25B | $1.21B | $1.05B | $943M | $675M | $972M |
| Inventory | $1.27B | $1.30B | $1.38B | $1.34B | $1.27B | $1.23B | $1.18B | $1.18B |
| Total current assets | $4.61B | $3.95B | $3.85B | $3.81B | $3.47B | $3.23B | $3.06B | $3.26B |
| Total assets | $8.59B | $7.59B | $7.61B | $7.46B | $7.15B | $6.99B | $6.85B | $7.07B |
| Long-term debt | $1.43B | $597M | — | — | — | — | — | — |
| Total liabilities | $2.38B | $1.51B | $1.56B | $1.43B | $1.35B | $1.33B | $1.44B | $1.78B |
| Total equity | $6.21B | $6.09B | $6.06B | $6.03B | $5.79B | $5.66B | $5.41B | $5.29B |